Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The trigeminal nerve (CN V) is the largest cranial nerve, responsible for sensory innervation of the face and motor innervation of the muscles of mastication. It has three main branches: ophthalmic (V1), maxillary (V2), and mandibular (V3). Disorders involving the trigeminal nerve include trigeminal neuralgia, characterized by severe facial pain, and facial paralysis or sensory loss due to injury or disease.
Variable, depending on the specific condition. For Trigeminal Neuralgia, medications aim to reduce neuronal excitability and pain signaling.
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Trigeminal Nerve (CN V).